Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Wayne D. Hall. (1998) Cannabis use and psychosis. Drug and Alcohol Review 17:4, pages 433-444.
Read now
Read now
Amanda J. Gruber & Harrison G. Pope. (1994) J Cannabis Psychotic Disorder. American Journal on Addictions 3:1, pages 72-83.
Read now
Read now
Beverly Fauman, Glenn Aldinger, Michael Fauman & Peter Rosen. (1976) Psychiatric Sequelae of Phencyclidine Abuse. Clinical Toxicology 9:4, pages 529-538.
Read now
Read now
Articles from other publishers (19)
Cláudia Carvalho & Maria A. Vieira-Coelho. (2022) Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms. Pharmacological Research 181, pages 106258.
Crossref
Crossref
Kiernan Dorney & Michael Murphy. (2020) Recommendations for the medical work‐up of first episode psychosis, including specific relevance to Indigenous Australians: A narrative review. Early Intervention in Psychiatry 15:3, pages 423-438.
Crossref
Crossref
Diego Quattrone, Laura Ferraro, Giada Tripoli, Caterina La Cascia, Harriet Quigley, Andrea Quattrone, Hannah E. Jongsma, Simona Del Peschio, Giusy Gatto, Charlotte Gayer-Anderson, Peter B. Jones, James B. Kirkbride, Daniele La Barbera, Ilaria Tarricone, Domenico Berardi, Sarah Tosato, Antonio Lasalvia, Andrei Szöke, Celso Arango, Miquel Bernardo, Julio Bobes, Cristina Marta Del Ben, Paulo Rossi Menezes, Pierre-Michel Llorca, Jose Luis Santos, Julio Sanjuán, Andrea Tortelli, Eva Velthorst, Lieuwe de Haan, Bart P. F. Rutten, Michael T. Lynskey, Tom P. Freeman, Pak C. Sham, Alastair G. Cardno, Evangelos Vassos, Jim van Os, Craig Morgan, Ulrich Reininghaus, Cathryn M. Lewis, Robin M. Murray & Marta Di Forti. (2020) Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study. Psychological Medicine 51:8, pages 1329-1337.
Crossref
Crossref
Angelo Maremmani, Matteo Pacini & Icro Maremmani. (2019) What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients. International Journal of Environmental Research and Public Health 16:3, pages 447.
Crossref
Crossref
Sai Krishna Tikka & Deepak Cyril D’Souza. 2019. Cannabis Use Disorders. Cannabis Use Disorders
127
155
.
Adam Michael Stewart & Allan V. Kalueff. (2014) The behavioral effects of acute Δ9-tetrahydrocannabinol and heroin (diacetylmorphine) exposure in adult zebrafish. Brain Research 1543, pages 109-119.
Crossref
Crossref
Rajiv Radhakrishnan, Peter H. Addy, R. Andrew Sewell, Patrick D. Skosnik, Mohini Ranganathan & Deepak Cyril D’Souza. 2014. The Effects of Drug Abuse on the Human Nervous System. The Effects of Drug Abuse on the Human Nervous System
423
474
.
R. Andrew Sewell, Patrick D. Skosnik, Icelini Garcia-Sosa, Mohini Ranganathan & Deepak Cyril D'Souza. (2010) Efeitos comportamentais, cognitivos e psicofisiológicos dos canabinoides: relevância para a psicose e a esquizofrenia. Revista Brasileira de Psiquiatria 32:suppl 1, pages 515-530.
Crossref
Crossref
Deepak Cyril D’Souza, Richard Andrew Sewell & Mohini Ranganathan. (2009) Cannabis and psychosis/schizophrenia: human studies. European Archives of Psychiatry and Clinical Neuroscience 259:7, pages 413-431.
Crossref
Crossref
Pál Pacher, Sándor Bátkai & George Kunos. (2006) The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacological Reviews 58:3, pages 389-462.
Crossref
Crossref
Icro Maremmani, Matteo Pacini, Antonio Lazzeri, Giulio Perugi & Joseph Deltito. (2006) Concurrent Abuse of Cannabis Is Associated with a Shorter Duration of Hospitalization in Treatment-Resistant Psychotic Bipolar Inpatients Treated with Clozapine. Addictive Disorders & Their Treatment 5:1, pages 1-7.
Crossref
Crossref
Yukitaka Morita, Hiroshi Ujike, Yuji Tanaka, Naohiko Uchida, Akira Nomura, Kyohei Ohtani, Makiko Kishimoto, Akiko Morio, Takaki Imamura, Ayumu Sakai, Toshiya Inada, Mutsuo Harano, Tokutaro Komiyama, Mitsuhiko Yamada, Yoshimoto Sekine, Nakao Iwata, Masaomi Iyo, Ichiro Sora, Norio Ozaki & Shigetoshi Kuroda. (2005) A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia. Neuroscience Letters 376:3, pages 182-187.
Crossref
Crossref
Wayne Hall & Louisa Degenhardt. 2009. Marijuana and Madness. Marijuana and Madness
89
100
.
Hiroshi Ujike & Yukitaka Morita. (2004) New Perspectives in the Studies on Endocannabinoid and Cannabis: Cannabinoid Receptors and Schizophrenia. Journal of Pharmacological Sciences 96:4, pages 376-381.
Crossref
Crossref
H Ujike, M Takaki, K Nakata, Y Tanaka, T Takeda, M Kodama, Y Fujiwara, A Sakai & S Kuroda. (2002) CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Molecular Psychiatry 7:5, pages 515-518.
Crossref
Crossref
Amanda J. Gruber & Harrison G. PopeJr.Jr.. (2010) Cannabis Psychotic Disorder. The American Journal on Addictions 3:1, pages 72-83.
Crossref
Crossref
Daniel Duprez. (1992) Selective steam reforming of aromatic compounds on metal catalysts. Applied Catalysis A: General 82:2, pages 111-157.
Crossref
Crossref
Brian G. Humblestone & David F. Allen. 1987. The Cocaine Crisis. The Cocaine Crisis
119
123
.
V. R. Thacore. (2018) Bhang Psychosis. British Journal of Psychiatry 123:573, pages 225-229.
Crossref
Crossref